Thomas Haalck

Targeted Therapy in Advanced Melanoma With Rare <i>BRAF</i> Mutations

Christian Menzer, Alexander M. Menzies, Matteo S. Carlino et al. · Journal of Clinical Oncology · 2019 · 124 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

T-cell diversification reflects antigen selection in the blood of patients on immune checkpoint inhibition and may be exploited as liquid biopsy biomarker

Nuray Akyüz, Anna Brandt, Alexander Stein et al. · International Journal of Cancer · 2016 · 50 citations · Full text

Life Sciences, Immunology, Oncology +17

Intermittent High-Dose Intravenous Interferon Alfa-2b for Adjuvant Treatment of Stage III Melanoma: Final Analysis of a Randomized Phase III Dermatologic Cooperative Oncology Group Trial

Peter Mohr, Axel Hauschild, Uwe Trefzer et al. · Journal of Clinical Oncology · 2015 · 34 citations

Medicine, Oncology, Pharmacotherapy +15

Knockdown of L1CAM significantly reduces metastasis in a xenograft model of human melanoma: L1CAM is a potential target for anti-melanoma therapy

Ann-Kathrin Ernst, Annika Putscher, Timur R. Samatov et al. · PLoS ONE · 2018 · 24 citations · Full text

Medicine, Molecular Biology, Oncology +16

Prognostic value of von Willebrand factor levels in patients with metastatic melanoma treated by immune checkpoint inhibitors

Julia-Christina Stadler, Laura Keller, Alexander T. Bauer et al. · Journal for ImmunoTherapy of Cancer · 2023 · 20 citations · Full text

Medicine, Immunology, Oncology +17